Galena Biopharma appoints interim CEO
Mr. Ghiglieri will also continue to serve as the Company’s Chief Financial Officer. Mr. Ghiglieri joined Galena Biopharma in November 2016 after previously consulting for the company.
Mr. Ghiglieri has more than 25 years in senior level finance and operational roles at both biotechnology and technology companies.
Prior to Galena, he served as CFO of MedData Inc., a private equity backed healthcare services company that was sold to Mednax, a publicly traded national medical group.
Previously, he spent nearly 10 years at NeurogesX, ending his tenure as the Company’s Executive Vice President, Chief Operating Officer and CFO.
Prior to that he served as the CFO of Hansen Medical, Inc., a medical device company. He also held senior level finance positions at two other healthcare companies: Oacis Healthcare Systems, Inc., and Oclassen Pharmaceuticals, Inc.
Additionally, Mr. Ghiglieri was the CFO and Corporate Secretary for two technology software companies: Avolent, Inc., and Andromedia, Inc.
He began his career as an audit manager of PricewaterhouseCoopers, LLP.
Mr. Ghiglieri received a Bachelor of Science in Business Administration from California State University, Hayward, where he graduated Magna Cum Laude. He is also a Certified Public Accountant (inactive). ■
What to read next
LATEST MOVES FROM California
- Reed's appoints Stefan Freeman as interim CEO
- Heron Therapeutics appoints Robert E. Hoffman as CFO
- Penumbra appoints Bridget O'Rourke to board
- Adverum Biotechnologies adds Richard N. Spivey to board
- Lombard Medical appoints Kurt Lemvigh as CEO
More inside POST